LaChapelle Robin bought AVBP

July 11, 2025 · Form 4 insider transaction

LaChapelle Robin bought 2,600 shares of ArriVent BioPharma, Inc. at $2.28 per share, a transaction worth $5.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
2,600
Price
$2.28
Total value
$5.9K
Role
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 11, 2025
Filing dateJuly 15, 2025
Shares owned after129,233
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR